Inflammation as a central mechanism in Alzheimer's disease

Kinney, Jefferson W., Bemiller, Shane M., Murtishaw, Andrew S., Leisgang, Amanda M., Salazar, Arnold M., Lamb, Bruce T.·2018·Alzheimer's & Dementia: Translational Research & Clinical Interventions

Cited by (1,008)

Items 301–400 of 1,008

  1. Long non-coding RNA ANRIL knockdown suppresses apoptosis and pro-inflammatory cytokines while enhancing neurite outgrowth via binding microRNA-125a in a cellular model of Alzheimer's disease
    Bingling Zhou, Lijuan Li, Xin Qiu, Jia‐shun Wu, Lei Xu, Wei Shao · 2020 · Molecular Medicine Reports · Retracted
  2. Protective Role of St. John’s Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies
    Michela Novelli, Pellegrino Masiello, Pascale Beffy, Marta Menegazzi · 2020 · International Journal of Molecular Sciences
  3. Inflammatory Diseases, Inflammatory Biomarkers, and Alzheimer Disease
    Jian V. Huang, Bowen Su, Ville Karhunen, Dipender Gill, Verena Zuber, Ari Ahola‐Olli, Saranya Palaniswamy, JUHA P. AUVINEN, Karl‐Heinz Herzig, Sirkka M Keinanen-Kiukaanniemi et al. · 2022 · Neurology
  4. Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
    Vanesa R. Hyde, Chaoming Zhou, J R Muñóz y Fernández, Krishnashis Chatterjee, Pururav Ramakrishna, Amanda Lin, Gregory W. Fisher, Orhan T. Celiker, Jill Caldwell, Omer Bender et al. · 2025 · Cell Reports
  5. Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
    Jun Liao, Wenxiu He, Lisha Li, Jingya Wang, Lidong Gong, Qiang Zhang, Zhiqiang Lin · 2025 · Cell Biomaterials
  6. Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy
    Xiaoying Sun, Quan-xiu Dong, Jie Zhu, Xun Sun, Lifan Zhang, Mandy Qiu, Xiaolin Yu, Rui‐tian Liu · 2019 · Current Alzheimer Research
  7. Role of Glia in the Regulation of Sleep in Health and Disease
    Stefano Garofalo, Katherine Picard, Cristina Limatola, Agnès Nadjar, Olivier Pascual, Marie‐Ève Tremblay · 2020 · Comprehensive physiology
  8. The Cell Biology of Tau Secretion
    Maria Merezhko, Riikka‐Liisa Uronen, Henri J. Huttunen · 2020 · Frontiers in Molecular Neuroscience
  9. GSK3β is involved in promoting Alzheimer’s disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor proteinNL-F/NL-F knock-in mice
    Muzhou Jiang, Xinwen Zhang, Xu Yan, Shinsuke Mizutani, Haruhiko Kashiwazaki, Junjun Ni, Zhou Wu · 2021 · Brain Behavior and Immunity
  10. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation
    So Yeong Cheon, Juhyun Song · 2022 · Cell & Bioscience
  11. Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review
    Valentina Lerose, Maria Ponticelli, Nadia Benedetto, Vittorio Carlucci, Ludovica Lela, Nikolay T. Tzvetkov, Luigi Milella · 2024 · Plants
  12. Astrocyte-mediated inflammatory responses in traumatic brain injury: mechanisms and potential interventions
    Haifeng Zhang, Xian Zhang, Yan Chai, Yuhua Wang, Jianning Zhang, Xin Chen · 2025 · Frontiers in Immunology
  13. Polysaccharide from Schisandra chinensis acts via LRP-1 to reverse microglia activation through suppression of the NF-κB and MAPK signaling
    Mengjie Xu, Jinyu Wang, Xiaoying Zhang, Tingxu Yan, Bo Wu, Kaishun Bi, Ying Jia · 2020 · Journal of Ethnopharmacology
  14. Prenatal exposure to bisphenol A alters the transcriptome-interactome profiles of genes associated with Alzheimer’s disease in the offspring hippocampus
    Suporn Sukjamnong, Surangrat Thongkorn, Songphon Kanlayaprasit, Thanit Saeliw, Kanlayaphat Hussem, Watis Warayanon, Valerie Wailin Hu, Tewin Tencomnao, Tewarit Sarachana · 2020 · Scientific Reports
  15. The Use of Antimicrobial and Antiviral Drugs in Alzheimer’s Disease
    Umar Iqbal, Emma Zeng, Giulio Maria Pasinetti · 2020 · International Journal of Molecular Sciences
  16. Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease
    Alex Cleber Improta Caria, Carolina Kymie Vasques Nonaka, Bruno Raphael Ribeiro Cavalcante, Ricardo Augusto Leoni De Sousa, Roque Aras, Bruno Solano de Freitas Souza · 2020 · International Journal of Molecular Sciences
  17. Extracellular Vesicles from Mesenchymal Stromal Cells for the Treatment of Inflammation-Related Conditions
    Sean Thomas Ryan, Elham Hosseini Beheshti, Dinara Afrose, Xianting Ding, Binbin Xia, Georges E. Grau, Christopher B. Little, Lana McClements, Jiao Jiao Li · 2021 · International Journal of Molecular Sciences
  18. Trace elements and Alzheimer dementia in population-based studies: A bibliometric and meta-analysis
    Kai Li, Ang Li, Yayuan Mei, Jiaxin Zhao, Quan Zhou, Yanbing Li, Ming Yang, Qun Xu · 2022 · Environmental Pollution
  19. Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach
    Gábor Katona, György Tibor Balogh, Gergő Dargó, Róbert Gáspár, Árpád Márki, Eszter Ducza, Anita Sztojkov‐Ivanov, Ferenc Tömösi, Gábor Kecskeméti, Tamás Janáky et al. · 2020 · Pharmaceutics
  20. Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model
    Xu‐Qiao Chen, Ahmad Salehi, Matthew L. Pearn, Cassia Overk, Phuong D. Nguyen, Alexander M. Kleschevnikov, Maria L. Maccecchini, William Cary Mobley · 2020 · Alzheimer s & Dementia
  21. Treating disorders across the lifespan by modulating cholinergic signaling with galantamine
    Christine Noel Metz, Valentin A. Pavlov · 2020 · Journal of Neurochemistry
  22. Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington’s disease via suppressing MAPKs and NF-κB pathways in the striatum
    Xiong Yang, Shifeng Chu, Zhen‐Zhen Wang, Fangfang Li, Yu‐He Yuan, Nai‐Hong Chen · 2020 · Acta Pharmacologica Sinica
  23. Creating and Validating a DNA Methylation-Based Proxy for Interleukin-6
    Anna J. Stevenson, Danni A. Gadd, Robert Francis Hillary, Daniel L. McCartney, Archie Campbell, Rosie May Walker, Kathryn Louise Evans, Sarah E. Harris, Tara L. Spires‐Jones, Allan F. McRae et al. · 2021 · The Journals of Gerontology Series A
  24. An overview of the pharmacological activities of scopoletin against different chronic diseases
    Dey Parama, Sosmitha Girisa, Elina Khatoon, Aviral Kumar, Mohammed Saeed Alqahtani, Mohamed Abd Elhamid Abbas, Gautam Sethi, Ajaikumar Bahulayan Kunnumakkara · 2022 · Pharmacological Research
  25. Lactobacillus-derived extracellular vesicles counteract Aβ42-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve Aβ pathology in Tg-APP/PS1 mice
    Hye‐Jin Kwon, Eun Hwa Lee, So‐Young Park, Jin‐Young Park, Jin-Hwan Hong, Eun‐Kyung Kim, Tae-Seop Shin, Yoon‐Keun Kim, Pyung‐Lim Han · 2023 · Experimental & Molecular Medicine
  26. Neuroprotective and Anti-neuroinflammatory Properties of Ebselen Derivatives and Their Potential to Inhibit Neurodegeneration
    Alexander D. Landgraf, Amsha S. Alsegiani, Saleh Ibrahim Alaqel, Sandeep Thanna, Zahoor Ahmad Shah, Steven J. Sucheck · 2020 · ACS Chemical Neuroscience
  27. Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer’s disease-like pathology?
    Miroslava Kacířová, Anna Zmeškalová, Lucia Kořínková, Blanka Železná, Jaroslav Kuneš, Lenka Maletı́nská · 2020 · Clinical Science
  28. Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer′s Disease
    Seung Hwan Son, Na‐Rae Lee, Min Sung Gee, Chae Won Song, Soojin Lee, Sang‐Kyung Lee, Yoonji Lee, Hee Jin Kim, Jong Kil Lee, Kyung‐Soo Inn et al. · 2023 · ACS Central Science
  29. Alzheimer’s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling
    Tao, Qing-Qing, Cai, Xue, Xue, Yan-Yan, Ge, Weigang, Yue, Liang, Li, Xiao-Yan, Lin, Rong-Rong, Peng, Guo-Ping, Jiang, Wenhao, Li, Sainan et al. · 2024 · The Innovation
  30. Grape seed proanthocyanidins ameliorate neuronal oxidative damage by inhibiting GSK-3β-dependent mitochondrial permeability transition pore opening in an experimental model of sporadic Alzheimer’s disease
    Qinru Sun, Ning Jia, Xin Li, Jie Yang, Guomin Chen · 2019 · Aging
  31. Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer’s Disease
    Emily M. Borsom, Keehoon Lee, Emily K. Cope · 2020 · Brain Sciences
  32. Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
    Cristina Popescu, Constantin Munteanu, Aurelian Anghelescu, Vlad Ciobanu, Aura Spînu, Ioana Andone, Mihaela Mandu, Roxana Bistriceanu, Mihai Băilă, Ruxandra-Luciana Postoiu et al. · 2024 · International Journal of Molecular Sciences
  33. Expression pattern of perilipins in human brain during aging and in Alzheimer's disease
    Maria Conte, Valentina Medici, Davide Malagoli, Antonio Chiariello, Alice Cirrincione, Annalisa Davin, Maia Chikhladze, Francesco Vasuri, Giuseppe Legname, Isidró Ferrer et al. · 2021 · Neuropathology and Applied Neurobiology
  34. pH Dependence of Amyloid‐β Fibril Assembly Kinetics: Unravelling the Microscopic Molecular Processes
    Yao Tian, John H. Viles · 2022 · Angewandte Chemie International Edition
  35. Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
    Ewa Rudnicka-Drożak, Paulina Drożak, Grzegorz Mizerski, Tomasz Zaborowski, Barbara Janina Ślusarska, Grzegorz Nowicki, Martyna Drożak · 2023 · International Journal of Environmental Research and Public Health
  36. Alzheimer’s disease: a mini-review for the clinician
    Rishi S. Madnani · 2023 · Frontiers in Neurology
  37. Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics
    Markus Rießland, Miranda E. Orr · 2023 · The Journal of Prevention of Alzheimer s Disease
  38. Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
    Wendy Balestri, Ruchi Sharma, Victor Allisson da Silva, Bianca Caroline Bobotis, Annabel J. Curle, Vandana Kothakota, Farnoosh Kalantarnia, Maria Victoria Hangad, Mina Hoorfar, Joanne Jones et al. · 2024 · Journal of Neuroinflammation
  39. Peripheral inflammatory biomarkers predict the deposition and progression of amyloid-β in cognitively unimpaired older adults
    Lauren E. Oberlin, Kirk I. Erickson, Rachel H. Mackey, William Edward Klunk, Howard Jay Aizenstein, Brian J. Lopresti, Lewis H. Kuller, Oscar L. López, Beth Ellen Snitz · 2021 · Brain Behavior and Immunity
  40. Is non-invasive brain stimulation effective for cognitive enhancement in Alzheimer’s disease? An updated meta-analysis
    Patrik Šimko, Julia Anna Kent, Irena Rektorová · 2022 · Clinical Neurophysiology
  41. Tacrine-Based Hybrids: Past, Present, and Future
    Anna Bubley, Alexander S. Erofeev, Petr V. Gorelkin, Elena Kimovna Beloglazkina, Alexander G. Majouga, Olga Olegovna Krasnovskaya · 2023 · International Journal of Molecular Sciences
  42. Extra-Virgin Olive Oil in Alzheimer’s Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies
    Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Amal Kaddoumi · 2024 · International Journal of Molecular Sciences
  43. The neuroimmune CGRP–RAMP1 axis tunes cutaneous adaptive immunity to the microbiota
    Warakorn Kulalert, Alexandria C. Wells, Verena M. Link, Ai Ing Lim, Nicolas Jean Bouladoux, Motoyoshi Nagai, Oliver J. Harrison, Olena Kamenyeva, Juraj Kabát, Michel Enamorado et al. · 2024 · Proceedings of the National Academy of Sciences
  44. Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins
    Chadarevian, Jean Paul, Davtyan, Hayk, Chadarevian, Alina L., Nguyen, Jasmine, Capocchi, Joia K., Le, Lauren, Escobar, Adrian, Chadarevian, Talar, Mansour, Kimiya, Deynega, Ekaterina et al. · 2025 · Cell Stem Cell
  45. Psychophysiological Responses in People Living with Dementia after an Art Gallery Intervention: An Exploratory Study
    Nathan Martin D'Cunha, Andrew J. McKune, Stephen T. Isbel, Jane Kellett, Ekavi N. Georgousopoulou, Nenad Naumovski · 2019 · Journal of Alzheimer s Disease
  46. HMGB1/RAGE/TLR4 axis and glutamate as novel targets for PCSK9 inhibitor in high fat cholesterol diet induced cognitive impairment and amyloidosis
    Abuelezz, Sally A., Hendawy, Nevien · 2021 · Life Sciences
  47. Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review
    Kochman, Urszula, Sitka, Hanna, Kuźniar, Julia, Czaja, Magdalena, Kozubek, Patrycja, Beszłej, Jan Aleksander, Leszek, Jerzy · 2026 · Molecular Neurobiology
  48. Purification, structural characterization, and cognitive improvement activity of a polysaccharides from Schisandra chinensis
    Xu, Mengjie, Yan, Tingxu, Gong, Guowei, Wu, Bo, He, Bosai, Du, Yiyang, Xiao, Feng, Jia, Ying · 2020 · International Journal of Biological Macromolecules
  49. Lupeol, a Plant-Derived Triterpenoid, Protects Mice Brains against Aβ-Induced Oxidative Stress and Neurodegeneration
    Riaz Ahmad, Amjad Khan, Hyeon Jin Lee, Inayat Ur Rehman, Ibrahim Khan, Sayed Ibrar Alam, Myeong Ok Kim · 2020 · Biomedicines
  50. The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study
    Xiaolei Shi, Tao Wei, Yachun Hu, Meng Wang, Yi Tang · 2022 · Journal of Neuroinflammation
  51. Metal Nanoparticles in Alzheimer’s Disease
    Behera, Anindita, Sa, Nishigandha, Pradhan, Sweta Priyadarshini, Swain, Sunsita, Sahu, Pratap Kumar · 2023 · Journal of Alzheimer's Disease Reports
  52. Exploring pathological link between antimicrobial and amyloid peptides
    Yijing Tang, Yanxian Zhang, Dong Zhang, Yonglan Liu, Ruth Nussinov, Jie Zheng · 2024 · Chemical Society Reviews
  53. Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease
    Wen Li, Qiuping Chen, Cheng Peng, Dan Yang, Si Liu, Yanwen Lv, Langqi Jiang, Shi‐Jun Xu, Huang Li-hua · 2025 · International Journal of Molecular Sciences
  54. New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study
    Nadia H. Metwally, Mona Said Mohamed · 2019 · Bioorganic Chemistry
  55. The Protective Effects and Potential Mechanisms of Ligusticum chuanxiong : Focus on Anti‐Inflammatory, Antioxidant, and Antiapoptotic Activities
    Jinhui Shi, Ruiyue Li, Siyu Yang, Yee Lin Phang, Changwu Zheng, Hongmei Zhang · 2020 · Evidence-based Complementary and Alternative Medicine
  56. Ensemble of ROI-based convolutional neural network classifiers for staging the Alzheimer disease spectrum from magnetic resonance imaging
    Samsuddin Ahmed, Byeong Chae Kim, Kun Ho Lee, Ho Yub Jung, Alzheimer’s Disease Neuroimaging Initiative · 2020 · PLoS ONE
  57. Postoperative cognitive dysfunction: an acute approach for the development of novel treatments for neuroinflammation
    Kiri T. Granger, Jennifer H. Barnett · 2021 · Drug Discovery Today
  58. The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease
    Mishra, Pranav, Davies, Don A., Albensi, Benedict C. · 2023 · Molecular Neurobiology
  59. C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study
    Chatterjee, Madhurima, Özdemir, Selcuk, Kunadt, Marcel, Koel‐Simmelink, Marleen, Boiten, Walter, Piepkorn, Lars, Pham, Thang V., Chiasserini, Davide, Piersma, Sander R., Knol, Jaco C. et al. · 2023 · Alzheimer's & Dementia
  60. NPTX2 in Cerebrospinal Fluid Predicts the Progression From Normal Cognition to Mild Cognitive Impairment
    Anja Soldan, Sungtaek Oh, Taekyung Ryu, Corinne A. Pettigrew, Yuxin Zhu, Abhay Moghekar, Meifang Xiao, Gregory M. Pontone, Marilyn Albert, Chan Hyun Na et al. · 2023 · Annals of Neurology
  61. Liposomal drug delivery of Aphanamixis polystachya leaf extracts and its neurobehavioral activity in mice model
    Mohammad Hossain Shariare, Mahbubur Rahman, Shamshad Rahman Lubna, Reeti S. Roy, Joynal Abedin, Akbar L. Marzan, Mohammad A. Altamimi, Syed Rizwan Ahamad, Ajaz Ahmad, Fars Kaed Alanazi et al. · 2020 · Scientific Reports
  62. Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment
    Shang Li, Lailiang Qu, Xiaobing Wang, Lingyi Kong · 2021 · Pharmacology & Therapeutics
  63. Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
    Jeffrey L. Cummings, Andrew Adonay Ortiz, Janelle Castellino, Jefferson W. Kinney · 2022 · European Journal of Neuroscience
  64. Zika virus infection accelerates Alzheimer’s disease phenotypes in brain organoids
    Seung‐Eun Lee, Hanul Choi, Nari Shin, Dasom Kong, Nam Gyo Kim, Hee-Yeong Kim, Minji Kim, Soon Won Choi, Young Bong Kim, Kyung‐Sun Kang · 2022 · Cell Death Discovery
  65. The Risk of Developing Alzheimer’s Disease and Parkinson’s Disease in Patients with Inflammatory Bowel Disease: A Meta-Analysis
    Marta Szandruk-Bender, Benita Wiatrak, Adam Szeląg · 2022 · Journal of Clinical Medicine
  66. Nature's toolbox against tau aggregation: An updated review of current research
    Sumaiya Khan, Md. Imtaiyaz Hassan, Mohammad Shahid, Asimul Islam · 2023 · Ageing Research Reviews
  67. Some promising medicinal plants used in Alzheimer’s disease: an ethnopharmacological perspective
    Smita Bordoloi, Kalyani Pathak, Mary Devi, Riya Saikia, Jyotirmoy Das, Vikrant Hari Kashyap, Dibyajyoti Das, Mohammad Zaki Ahmad, Basel A. Abdel‐Wahab · 2024 · Discover Applied Sciences
  68. Perivascular space enlargement accelerates in ageing and Alzheimer’s disease pathology: evidence from a three-year longitudinal multicentre study
    Inga Menze, Jose Bernal, Pinar Kaya, Çağla Akı, Malte Pfister, Jonas Geisendörfer, Renat Yakupov, Roberto Duarte Coello, María Valdés Hernández, Michael Thomas Heneka et al. · 2024 · Alzheimer s Research & Therapy
  69. Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes
    Stanciu, Gabriela Dumitrita, Rusu, Razvan Nicolae, Bild, Veronica, Filipiuc, Leontina Elena, Tamba, Bogdan-Ionel, Ababei, Daniela Carmen · 2021 · Biomedicines
  70. Can mouse models mimic sporadic Alzheimer’s disease?
    Humpel, Christian, Foidl, BettinaM · 2020 · Neural Regeneration Research
  71. Neutrophil to lymphocyte ratio in parkinson’s disease: a systematic review and meta-analysis
    Samaneh Hosseini, N Shafiabadi, Monireh Khanzadeh, Arshin Ghaedi, Raziyeh Ghorbanzadeh, Amir Azarhomayoun, Aida Bazrgar, Jalil Pezeshki, Hanieh Bazrafshan, Shokoufeh Khanzadeh · 2023 · BMC Neurology
  72. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease–A step towards mitochondria based therapeutic strategies
    Khadga Raj Aran, Shamsher Singh · 2023 · Aging and Health Research
  73. Inflammation unites diverse acute and chronic diseases
    Peter Libby, Robin D. Smith, Eric J. Rubin, Marilyn K. Glassberg, Michael E. Farkouh, Robert S. Rosenson · 2024 · European Journal of Clinical Investigation
  74. Implicating neuroinflammation in hippocampus, prefrontal cortex and amygdala with cognitive deficit: a narrative review
    Vandana Blossom, Sheetal Dinkar Ullal, Melisha M. D’Souza, Anu Vinod Ranade, Nayanatara Arun Kumar, Rajalakshmi Rai · 2025 · 3 Biotech
  75. Alzheimer’s Disease: What Can We Learn From the Peripheral Olfactory System?
    Michele Dibattista, Simone Pifferi, Anna Menini, Johannes Reisert · 2020 · Frontiers in Neuroscience
  76. Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study
    Valentina Cecarini, Laura Bonfili, Olee Gogoi, Solomon Lawrence, Franco Maria Venanzi, Vasco Azevedo, Pamela Del Carmen Mancha-Agresti, Mariana Martins Drumond, Giacomo Rossi, Sara Berardi et al. · 2020 · Aging
  77. Long-Term Consequence of Non-neurotropic H3N2 Influenza A Virus Infection for the Progression of Alzheimer’s Disease Symptoms
    Shirin Hosseini, Kristin Michaelsen‐Preusse, Klaus Schughart, Martin Körte · 2021 · Frontiers in Cellular Neuroscience
  78. Inhibition of A1 Astrocytes and Activation of A2 Astrocytes for the Treatment of Spinal Cord Injury
    Jingxuan Wang, Cai Cheng, Zhongbing Liu, Yan Lin, Lingling Yang, Zijun Zhang, Xiaoduan Sun, Meiling Zhou, Pei Jing, Zhirong Zhong · 2022 · Neurochemical Research
  79. TREM2 expression and amyloid‐beta phagocytosis in Alzheimer's disease
    La Rosa, Francesca, Agostini, Simone, Piancone, Federica, Marventano, Ivana, Hernis, Ambra, Fenoglio, Chiara, Galimberti, Daniela, Scarpini, Elio, Saresella, Marina, Clerici, Mario · 2023 · International Journal of Molecular Sciences
  80. Nobiletin regulates intracellular Ca2+ levels via IP3R and ameliorates neuroinflammation in Aβ42-induced astrocytes
    Sanjay Sanjay, Rachit Sood, Varun K. Jaiswal, Sung-Ung Kang, Miey Park, Hae‐Jeung Lee · 2024 · Redox Biology
  81. Targeting of Extracellular Vesicle-Based Therapeutics to the Brain
    Anastasia Williams, Heather Branscome, Fatah Kashanchi, Elena V. Batrakova · 2025 · Cells
  82. The Role of Inflammation in Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis
    Justyna Fołta, Zuzanna Rzepka, Dorota Małgorzata Wrześniok · 2025 · International Journal of Molecular Sciences
  83. Poly (ethylene glycol)-block-poly (D, L-lactide) (PEG-PLA) micelles for brain delivery of baicalein through nasal route for potential treatment of neurodegenerative diseases due to oxidative stress and inflammation: An in vitro and in vivo study
    Zhang Li, Shili Yang, Lizhen Huang, Paul C. Ho · 2020 · International Journal of Pharmaceutics
  84. Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go
    Pragya Prasanna, Arun Upadhyay · 2021 · ACS Pharmacology & Translational Science
  85. Application of Marine Natural Products against Alzheimer’s Disease: Past, Present and Future
    Di Hu, Yating Jin, Xiangqi Hou, Yinlong Zhu, Danting Chen, Jingjing Tai, Qianqian Chen, Cui Shi, Jing Ye, Mengxu Wu et al. · 2023 · Marine Drugs
  86. Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies
    Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, Thilo van Eimeren, Gilbert Wunderlich, Hans Zempel · 2024 · Journal of Neurology
  87. Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs
    Akhil Sood, Mukaila A. Raji · 2020 · Clinical Rheumatology
  88. Predicting Neurodegenerative Disease Using Prepathology Gut Microbiota Composition: a Longitudinal Study in Mice Modeling Alzheimer’s Disease Pathologies
    Emily M. Borsom, Kathryn A Conn, Christopher R. Keefe, Chloe Herman, Gabrielle M Orsini, Allyson H. Hirsch, Melanie Palma Avila, George Testo, Sierra A. Jaramillo, Evan K Bolyen et al. · 2023 · Microbiology Spectrum
  89. PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice
    Vilella, Antonietta, Bodria, Martina, Papotti, Bianca, Zanotti, Ilaria, Zimetti, Francesca, Remaggi, Giulia, Elviri, Lisa, Potì, Francesco, Ferri, Nicola, Lupo, Maria Giovanna et al. · 2024 · Brain, Behavior, and Immunity
  90. Gut microbial involvement in Alzheimer's disease pathogenesis
    Yu Zhang, Rulin Geng, Qiuyun Tu · 2021 · Aging
  91. Highlighting Immune System and Stress in Major Depressive Disorder, Parkinson’s, and Alzheimer’s Diseases, with a Connection with Serotonin
    Ana Salomé Correia, Armando Cardoso, Nuno Vale · 2021 · International Journal of Molecular Sciences
  92. Role of neurotoxicants in the pathogenesis of Alzheimer’s disease: a mechanistic insight
    Fatema Yasmin Nisa, Md. Atiar Rahman, Md. Amjad Hossen, Mohammad Forhad Khan, Md. Asif Nadim Khan, Mumtahina Majid, Farjana Sultana, Md. Areeful Haque · 2021 · Annals of Medicine
  93. CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study
    Low, Audrey, Prats-Sedano, Maria A, Stefaniak, James D, McKiernan, Elizabeth Frances, Carter, Stephen F, Douvani, Maria-Eleni, Mak, Elijah, Su, Li, Stupart, Olivia, Muniz, Graciela et al. · 2022 · Journal of Neurology, Neurosurgery & Psychiatry
  94. Targeting complement in neurodegeneration: challenges, risks, and strategies
    Wioleta Milena Zelek, B. Paul Morgan · 2022 · Trends in Pharmacological Sciences
  95. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
    Xavier Morató, Marta Marquié, Juan Pablo Tartari, Asunción Lafuente, Carla Abdelnour Ruiz, Montserrat Alegret, Sara Jofresa, Mar Buendía, Ana Pancho, Núria Aguilera et al. · 2023 · Scientific Reports
  96. Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review
    Himanshi Yadav, Jaldhi, Rati Bhardwaj, Anamika Anamika, Amrita Bakshi, Suchi Gupta, Shashank Kumar Maurya · 2023 · Life Sciences
  97. Associations of infections and vaccines with Alzheimer's disease point to a role of compromised immunity rather than specific pathogen in AD
    Svetlana V. Ukraintseva, Arseniy Pavlovich Yashkin, Igor V. Akushevich, Konstantin G. Arbeev, Hongzhe Duan, Galina Gorbunova, Eric Stallard, Anatoliy I. Yashin · 2024 · Experimental Gerontology
  98. Evaluating the effect of rapamycin treatment in Alzheimer’s disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol
    Jonas E. Svensson, Martin Bolin, Daniel Thor, Pete A. Williams, Rune Brautaset, Marcus Carlsson, Peder Sörensson, David Marlevi, Rubens Spin‐Neto, Monika Probst et al. · 2024 · BMC Neurology
  99. Mechanistic complexities of bone loss in Alzheimer’s disease: a review
    Frame, Gabrielle, Bretland, Katie A., Dengler-Crish, Christine M. · 2020 · Connective Tissue Research
  100. Gut dysbiosis in stroke and its implications on Alzheimer’s disease‐like cognitive dysfunction
    Justin Cho, You Jeong Park, Bella Gonzales‐Portillo, Madeline Saft, Blaise Cozene, Nadia Sadanandan, Cesar V. Borlongan · 2021 · CNS Neuroscience & Therapeutics